Theratechnologies (NASDAQ:THTX) Announces Earnings Results

Theratechnologies (NASDAQ:THTX) announced its quarterly earnings results on Wednesday. The company reported $0.02 EPS for the quarter, beating analysts’ consensus estimates of ($0.02) by $0.04, Yahoo Finance reports. The firm had revenue of $22.02 million for the quarter. During the same quarter last year, the firm earned ($0.40) earnings per share. Theratechnologies updated its FY 2024 guidance to EPS.

Theratechnologies Stock Performance

Shares of NASDAQ THTX opened at $1.45 on Friday. The firm has a 50 day moving average price of $1.30 and a two-hundred day moving average price of $1.47. Theratechnologies has a 52-week low of $0.88 and a 52-week high of $3.60.

About Theratechnologies

Theratechnologies Inc, a biopharmaceutical company, focuses on the development and commercialization of various therapies to address the unmet medical needs in the United States, Canada, and Europe. The company offers EGRIFTA SV for the reduction of excess abdominal fat in human immunodeficiency virus (HIV)-infected patients with lipodystrophy; and Trogarzo for the treatment of HIV-1 infection in heavily treatment-experienced adults with multidrug-resistant HIV-1 infection failing their current antiretroviral regimen.